R Hoffman
- Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation 26
- Platelet Disorders and Treatments 15
- Chronic Myeloid Leukemia Treatments 10
- Acute Myeloid Leukemia Research 8
- Multiple Myeloma Research and Treatments 7
- Genetics top 2%
- Mesenchymal stem cell research 12
- Myeloproliferative Neoplasms: Diagnosis and Treatment 7
- Immunology top 5%
- Immunotherapy and Immune Responses 6
- Internal Medicine top 5%
- Oncology top 10%
- Cited by
- HematologyGeneticsImmunology
- Partner nations
- United StatesIsraelItaly
In The Last Decade
R Hoffman
68 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 79
- Hematology 1.4k
- Genetics 470
- Immunology 610
- Internal Medicine 88
- Oncology 374
Countries citing papers authored by R Hoffman
This map shows the geographic impact of R Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Hoffman more than expected).
Fields of papers citing papers by R Hoffman
This network shows the impact of papers produced by R Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Hoffman. The network helps show where R Hoffman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R Hoffman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 24 | |
| 2 | 2013 | 10 | |
| 3 | 2013 | 14 | |
| 4 | 2006 | 22 | |
| 5 | 2006 | 15 | |
| 6 | 2005 | 134 | |
| 7 | 2001 | 40 | |
| 8 | 1999 | 39 | |
| 9 | 1997 | 46 | |
| 10 | 1996 | 13 | |
| 11 | Hematopoietic stem cell behavior: potential implications for gene therapy. | 1995 | 2 |
| 12 | Enriched hematopoietic stem cells: basic biology and clinical utility. | 1995 | 20 |
| 13 | 1994 | 8 | |
| 14 | 1993 | 11 | |
| 15 | 1993 | 8 | |
| 16 | 1993 | 4 | |
| 17 | 1992 | 2 | |
| 18 | Recombinant GM-CSF/IL-3 fusion protein: its effect on in vitro human megakaryocytopoiesis. | 1992 | 23 |
| 19 | 1990 | 15 | |
| 20 | New insights into the regulation of human megakaryocytopoiesis. | 1987 | 23 |
About R Hoffman
R Hoffman is a scholar working on Hematology, Genetics and Gastroenterology, having authored 68 papers that have together received 2.0k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (26 papers), Platelet Disorders and Treatments (15 papers), Mesenchymal stem cell research (12 papers), Chronic Myeloid Leukemia Treatments (10 papers), Acute Myeloid Leukemia Research (8 papers), Multiple Myeloma Research and Treatments (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and Immunotherapy and Immune Responses (6 papers). The work is most often cited by research in Hematology (1.4k citations), Genetics (470 citations) and Immunology (610 citations). R Hoffman has collaborated with scholars based in United States, Israel and Italy. Frequent co-authors include EF Srour, JE Brandt, T Leemhuis, J Brandt, RA Briddell, Benjamin Brenner, E Bruno, RA Briddell, Guido Tricot and Kapil N. Bhalla. Their work appears in journals such as Blood, Thrombosis and Haemostasis, Haematologica, Experimental Hematology and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.